Navigation Links
Combating Myths About Seasonal Allergies
Date:3/13/2011

SUNDAY, March 13 (HealthDay News) -- With spring allergy season looming, people need to know the facts about controlling their allergies, says the American College of Allergy, Asthma and Immunology.

According to the ACAAI:

  • Over-the-counter (OTC) oral antihistamines are less effective than prescription medicines in controlling a stuffy nose. OTC antihistamines may control some allergy symptoms but have little effect on relieving a stuffy nose or inflammation that often occurs with allergies.
  • OTC decongestant nasal sprays are not addictive. However, overuse leads to the need to use more and more nasal spray in order to get congestion relief. Don't use an OTC decongestant nasal spray for more than three days in a row.
  • Eating local honey will not combat spring allergies.
  • Pollen allergies can lead to food allergies. About one-third of people with pollen allergies also may react to certain foods because some pollens and foods have similar proteins. The reaction is usually mild and may include itchy, tingling mouth, throat or lips.
  • Skin tests are more sensitive than blood tests for diagnosing allergies.
  • Allergy shots are not necessarily more costly or time-consuming than taking medicine to relieve allergy symptoms. Over time, in fact, they may reduce an allergic person's health-care costs.

More information

The American Academy of Otolaryngology -- Head and Neck Surgery has more about allergies and hay fever.

-- Robert Preidt

SOURCE: American College of Allergy, Asthma and Immunology, news release, Feb. 25, 2011


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1

Related medicine news :

1. Holistic Management and Allan Savory Win the 2010 Buckminster Fuller Award for Turning Deserts into Thriving Grasslands and Combating Climate Change.
2. Combating cancers double whammy
3. Chew on this: 6 dental myths debunked
4. Health Bites: 8 Things You Didnt Know About Your Teeth
5. Virtual Global Highlights Top Ten Misconceptions about Cloud Computing
6. Connecticut Board Considers Warning About Risk Of Stroke Following Chiropractic Neck Manipulation
7. CIBA VISION Partners with TLC's Carmindy to Educate Consumers About Healthy Eye Habits
8. PDA Reminds Parents About the Importance of Childrens Oral Health
9. Its Time To Talk About It in the Chicago Community and Nationwide
10. Tiny molecules may tell big story about cardiovascular disease risk
11. David Anderson to discuss what model organisms can teach us about emotion
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Combating Myths About Seasonal Allergies
(Date:4/26/2017)... ... April 26, 2017 , ... New ... of ready-to-drink, high-protein beverages by helping beverage manufacturers more effectively manage protein costs. ... direct cost savings as well as more stable pricing over time. Now it’s ...
(Date:4/26/2017)... ... April 26, 2017 , ... MYOLYN, a medical ... that it has received 510(k) clearance from the U.S. Food & Drug Administration ... Pro. , Both devices are stationary cycling systems that use MYOLYN’s patent-pending ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... collaboration, announces Mirroring360 Pro . This new addition to the Mirroring360 product ... for education and business. , Mirroring360 Pro enables educators, business professionals and individuals ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... Beach, California, committed to raising awareness for Duchenne muscular dystrophy, and funding ... randomized CAP-1002 (cardiosphere-derived cells) Phase I/II HOPE clinical trial in Duchenne announced ...
(Date:4/25/2017)... , ... April 25, 2017 , ... ... CFOs and HR decision-makers are preparing for how his administration could impact the ... provide insight into what changes are most likely to make it through Congress. ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... April 19, 2017 The Mobile X-Ray product segment ... healthy CAGR during the forecast period Mobile X-Ray ... global digital mobile X-Ray devices market, which is estimated to ... expanding at a CAGR of 7% over the forecast period. ... of more than US$ 100 Mn in 2017 over 2016. ...
(Date:4/19/2017)... Global Prostate Cancer Therapeutics Market: Overview ... cancer therapeutics market analyzes the current and future ... prostate cancer, launch of promising emerging therapies, as ... drugs & therapeutic biological products, and high growth ... side effects are some of the drivers expected ...
(Date:4/19/2017)...  Sorrento Therapeutics, Inc. (NASDAQ: SRNE ... new treatments for cancer and other unmet medical ... announced underwritten public offering of 23,625,084 shares of ... of $2.00 per share, before deducting underwriting discounts ... Sorrento.  The net proceeds to Sorrento from this ...
Breaking Medicine Technology: